The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
This new facility strengthens Latin America as a collaborative hub
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
IKS Health's innovative solution orchestrates a roll out of critical operations functions into a unified and efficient connected workflow
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
Zaltenibart offers best-in-class potential across multiple rare blood and kidney disorders, enhancing Novo Nordisk’s rare disease portfolio
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
Subscribe To Our Newsletter & Stay Updated
